Eli Lilly has launched a new program that enables self-pay out sufferers to purchase the weight-loss drug Zepbound for as small as $399 every month—a lot less than 50 percent the checklist price of other incretin medicines employed for individuals with obesity.No, Tirzepatide will not be insulin. It is a GLP-1 and GIP receptor agonist that assist